Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma

Jonathon W. Senefeld(Mayo Clinic), Michael J. Joyner(Mayo Clinic), Matthew N.P. Vogt(Johns Hopkins University), Chad C. Wiggins(Johns Hopkins University), Andrew J. Clayburn(Johns Hopkins University), Camille M. van Buskirk(Johns Hopkins University), Stephen A. Klassen(Johns Hopkins University), Allan M. Klompas(Johns Hopkins University), Rickey E. Carter(Mayo Clinic in Florida), Katelyn A. Bruno(Mayo Clinic in Florida), M. Petersen(Mayo Clinic in Arizona), Emily R. Whelan(Mayo Clinic in Florida), John R.A. Shepherd(Johns Hopkins University), Kylie J. Andersen(Johns Hopkins University), James R. Stubbs(Johns Hopkins University), Jeffrey L. Winters(Mayo Clinic in Arizona), Michael A. Golafshar, Janis E. Blair(NorthShore University HealthSystem), Noud van Helmond(Johns Hopkins University), Philippe R. Bauer(Mayo Clinic in Florida), Robert F. Rea(Harvard–MIT Division of Health Sciences and Technology), Vitaly Herasevich(Mayo Clinic in Florida), Matthew A. Sexton(Johns Hopkins University), Katie L. Kunze(Mayo Clinic in Arizona), R. Scott Wright(Mayo Clinic in Arizona), Patrick W. Johnson(Mayo Clinic in Florida), Kathryn F. Larson(Johns Hopkins University), Sarah E. Baker(Johns Hopkins University), Juan G. Ripoll(Johns Hopkins University), Katherine Wright(Arizona State University), Nicole Verdun(Center for Biologics Evaluation and Research), Riley J. Regimbal(Johns Hopkins University), Nigel Paneth, Arturo Casadevall(Johns Hopkins University), DeLisa Fairweather(Johns Hopkins University), Matthew Buras, Joshua J. Dennis(Johns Hopkins University), Joel T. Greenshields(Indiana University Bloomington), Juan C. Diaz Soto(Johns Hopkins University), Peter Marks(Johns Hopkins University)
medRxiv
April 11, 2021
Cited by 7


Related Papers